BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17683250)

  • 1. Antibiological barrier nanovector technology for cancer applications.
    Sakamoto J; Annapragada A; Decuzzi P; Ferrari M
    Expert Opin Drug Deliv; 2007 Jul; 4(4):359-69. PubMed ID: 17683250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic therapeutic delivery using navigable agents.
    Martel S
    Ther Deliv; 2014 Feb; 5(2):189-204. PubMed ID: 24483196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptides for cancer therapy: a drug-development opportunity and a drug-delivery challenge.
    Bidwell GL
    Ther Deliv; 2012 May; 3(5):609-21. PubMed ID: 22834405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery via lipoprotein-based carriers: answering the challenges in systemic therapeutics.
    Sabnis N; Lacko AG
    Ther Deliv; 2012 May; 3(5):599-608. PubMed ID: 22834404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanodrug delivery systems: a promising technology for detection, diagnosis, and treatment of cancer.
    Babu A; Templeton AK; Munshi A; Ramesh R
    AAPS PharmSciTech; 2014 Jun; 15(3):709-21. PubMed ID: 24550101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery systems using polymer nanoassemblies for cancer treatment.
    Bae Y
    Ther Deliv; 2010 Sep; 1(3):361-3. PubMed ID: 22816139
    [No Abstract]   [Full Text] [Related]  

  • 9. Biophotonic techniques for manipulation and characterization of drug delivery nanosystems in cancer therapy.
    Spyratou E; Makropoulou M; Mourelatou EA; Demetzos C
    Cancer Lett; 2012 Dec; 327(1-2):111-22. PubMed ID: 22265863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmed drug delivery: nanosystems for tumor targeting.
    Wagner E
    Expert Opin Biol Ther; 2007 May; 7(5):587-93. PubMed ID: 17477797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicine: An effective tool in cancer therapy.
    Aftab S; Shah A; Nadhman A; Kurbanoglu S; Aysıl Ozkan S; Dionysiou DD; Shukla SS; Aminabhavi TM
    Int J Pharm; 2018 Apr; 540(1-2):132-149. PubMed ID: 29427746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomes and inorganic nanoparticles for drug delivery and cancer imaging.
    Heneweer C; Gendy SE; Peñate-Medina O
    Ther Deliv; 2012 May; 3(5):645-56. PubMed ID: 22834408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbon-based drug delivery carriers for cancer therapy.
    Lim DJ; Sim M; Oh L; Lim K; Park H
    Arch Pharm Res; 2014 Jan; 37(1):43-52. PubMed ID: 24234911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in image-guided intratumoral drug delivery techniques.
    Solorio L; Patel RB; Wu H; Krupka T; Exner AA
    Ther Deliv; 2010 Aug; 1(2):307-22. PubMed ID: 22816134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano drug-delivery systems in cancer therapy: gains, pitfalls and considerations in DMPK and PD.
    Elbayoumi TA
    Ther Deliv; 2010 Aug; 1(2):215-9. PubMed ID: 22816128
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid-polymer hybrid nanocarrier-mediated cancer therapeutics: current status and future directions.
    Garg NK; Tandel N; Jadon RS; Tyagi RK; Katare OP
    Drug Discov Today; 2018 Sep; 23(9):1610-1621. PubMed ID: 29857164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nanotechnology in pharmaceutical product development.
    Devalapally H; Chakilam A; Amiji MM
    J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.
    Liboiron BD; Mayer LD
    Ther Deliv; 2014 Feb; 5(2):149-71. PubMed ID: 24483194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in aptamer-armed multimodal theranostic nanosystems for imaging and targeted therapy of cancer.
    Vandghanooni S; Eskandani M; Barar J; Omidi Y
    Eur J Pharm Sci; 2018 May; 117():301-312. PubMed ID: 29499349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size matters: gold nanoparticles in targeted cancer drug delivery.
    Dreaden EC; Austin LA; Mackey MA; El-Sayed MA
    Ther Deliv; 2012 Apr; 3(4):457-78. PubMed ID: 22834077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.